LYNPARZA Patient Assistance Program
Don’t let the cost of cancer treatment compromise your care. We help eligible patients
access Lynparza (olaparib) for as little as $69.95 per month through manufacturer
Patient Assistance Programs.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Lynparza is the most widely prescribed PARP inhibitor in the world — treating four major cancer types (ovarian, breast, prostate, and pancreatic) that carry BRCA or HRR gene mutations.
- Retail price is approximately $8,741 per 60 tablets and up to $17,482 per month at the standard 300 mg twice-daily dose — totaling up to $210,000 per year (verified April 2026).
- AffordMyPrescriptions provides access to Lynparza for just $69.95/month through the Patient Assistance Program — because your genetic mutation should determine your treatment, not your bank balance.
- No generic version of olaparib is available in the United States; generic entry is not expected in the near term due to patent protections.
What is Lynparza Prescription Assistance Program?
The Lynparza Prescription Assistance Program is a manufacturer-sponsored initiative that provides Lynparza at no medication cost to qualifying patients. The program is accessible through the manufacturer’s patient support services. Financial assistance is available for commercially insured patients, uninsured patients, and those who have been denied insurance coverage.
When genetic testing reveals that your cancer carries a BRCA mutation — and your oncologist tells you that a targeted therapy exists that can exploit this specific vulnerability — the hope is immediate and profound. Discovering that this lifesaving medication costs $8,741 or more per month can shatter that hope just as quickly.
AffordMyPrescriptions ensures that your cancer’s genetic profile, not your financial profile, determines your treatment options. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment with the urgency that a cancer diagnosis demands. Medicare Part D patients are accepted.
Pharmacy Price Comparison
- Without assistance, Lynparza can cost hundreds or thousands of dollars per month at retail pharmacies. Discount programs offer some relief, but they don't come close to what a Patient Assistance Program provides, if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$8,795.00 | Save ~$8,725/mo |
| CVS Pharmacy | ~$8,840.00 | Save ~$8,770/mo |
| Walmart | ~$8,790.00 | Save ~$8,720/mo |
| Costco | ~$8,770.00 | Save ~$8,700/mo |
| Kroger | ~$8,800.00 | Save ~$8,730/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
Our advocacy service pricing is simple and predictable. The cost is based on the number of medications enrolled in our service — not on the retail price of your prescriptions. Most patients pay just $69.95/month for full advocacy on a single medication.
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Lynparza Prescription Program?
A cancer diagnosis driven by a genetic mutation carries a unique emotional weight — it’s not just a disease that happened to you, it’s written into your DNA. When your oncologist prescribes Lynparza because genetic testing confirmed that your cancer has the specific vulnerability this drug targets, maintaining consistent access is critical — interrupting treatment can allow cancer to progress.
From the moment you enroll, your advocate takes full ownership of your case. They prepare your application, coordinate with your oncologist to gather the required medical documentation (including genetic test results confirming your BRCA or HRR mutation status), submit everything to the appropriate program, and track your status through each stage of the approval process.
Our pricing is simple and predictable: $69.95 per month — every month, without exception. There are no hidden fees, no annual savings caps, no copay accumulator concerns. While the medication itself is provided at no cost through the assistance program, our monthly fee covers professional advocacy,
application management, oncologist coordination, and specialty pharmacy oversight. If we’re unable to secure access, you won’t be charged.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Manufacturer cards have annual benefit caps and require renewal
- Still $8,741–$17,482/month with best discount
- Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95 for the treatment course — never changes
- No expiration — continuous access as long as you qualify
- Lynparza supplied at no medication cost through specialty pharmacy
- We manage all paperwork, refills, and annual re-enrollment
- Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Lynparza Prescription From A Licensed U.S. Oncologist
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- Medicare Part D Patients Welcome
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Lynparza:
Lynparza (olaparib) is a twice-daily prescription oral tablet used to treat adults with certain types of ovarian, breast, prostate, and pancreatic cancer that have specific genetic mutations — most commonly BRCA mutations or other homologous recombination repair (HRR) gene mutations. Lynparza is a PARP inhibitor, a targeted cancer therapy that prevents cancer cells from repairing their damaged DNA.
How It Works:
Lynparza utilizes a concept called “synthetic lethality” to selectively target cancer cells with BRCA or HRR mutations. These cancer cells lack one DNA repair pathway and rely on the PARP enzyme as a backup to survive. By blocking PARP, Lynparza eliminates the cancer cells’ final repair mechanism, causing them to die from accumulated DNA damage. Because healthy cells still have a functioning repair pathway, they are largely spared from this toxic effect.
Form and Use:
This medication is produced in tablet form, available in strengths of 100 mg and 150 mg. the standard prescribed dosage is 300 mg, which consists of taking two 150 mg tablets twice every day. These doses should be taken at approximately the same times each day and can be consumed either with or without food.
Generic Availability:
As of April 2026, there is no FDA-approved generic version of Lynparza (olaparib) available in the United States due to ongoing patent protection. While generic versions exist in other countries, they cannot be legally sold in the U.S. until domestic patents expire. For those needing financial help, the Patient Assistance Program through AffordMyPrescriptions offers the medication at no cost for a monthly fee of $69.95.
Warnings:
Lynparza is associated with serious potential side effects, including lung problems like pneumonitis and bone marrow issues such as myelodysplastic syndrome. It can also cause significant harm to an unborn baby, making effective birth control essential during and after treatment. Patients must not discontinue the medication without first consulting their oncologist to ensure their safety
FAQ (Frequently Asked Questions)
How much does Lynparza cost without insurance?
Lynparza costs approximately $8,741 for 60 tablets, and the standard dose of 300 mg twice daily requires approximately 120 tablets per month (approximately $17,482/month). The manufacturer offers a $0 copay program for commercially insured patients with savings of up to $26,000/year. Through AffordMyPrescriptions, qualifying patients receive Lynparza at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Is this the same Lynparza I'd get at a pharmacy?
Yes. The Lynparza provided through the Patient Assistance Program is the identical FDA approved medication that would be dispensed at any specialty pharmacy. The only difference is that you pay no medication cost.
Is there a generic version of Lynparza?
No. As of April 2026, there is no FDA-approved generic version of olaparib in the United States. Lynparza remains patent-protected and is available only as the brand-name product.
Can I get Lynparza through the PAP if I have Medicare?
Yes. Medicare Part D patients are accepted into our advocacy program. With the 2026 Medicare Part D out-of-pocket cap of $2,100 per year, our advocates can also help you understand how Medicare may interact with your Lynparza access. We’ll work to find the most affordable pathway for your specific situation.
What if my application is denied?
Our Patient Advocates will immediately explore every alternative — including the manufacturer’s $0 copay savings program (for commercially insured patients), independent co- pay assistance foundations (PAN Foundation, HealthWell Foundation, CancerCare), Medicare.Extra Help for eligible beneficiaries, insurance prior authorization appeals, and alternative PARP inhibitors that may have different coverage on your plan. If we cannot secure assistance, you won’t be charged.
How long does it take to get approved?
Most applications are processed within 2–4 weeks. Because cancer treatment is time-sensitive,our advocates prioritize rapid processing and can often help arrange a transition supply through the manufacturer while your PAP application is pending.
Take Control of Your Medication Costs
If you are struggling with the high cost of Lynparza, our team may be able to help you
access assistance programs designed to make medications more affordable. Check
your eligibility today and take the first step toward reducing your prescription costs.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.